MENS: Utang jangka cendhak perusahaan Jyong Biotech Ltd

Jyong Biotech Ltd (MENS) develops safe botanical remedies for urology while minimizing side effects. The short-term borrowing level reflects current liability dynamics, where the metric value stands at 0.00. Asset stability depends on FDA approval and cost control. The company is currently focusing on organic growth and seeking global distribution partners for its medications.

To stress-test liquidity, an investor must analyze the dynamics of liabilities with maturities of up to one year, which allows for an assessment of the real debt load without accounting for accounting delays. Amid the expansion of Jyong Biotech Ltd (MENS) in the growing men's preventive medicine market, current loans and borrowings demonstrate effective working capital management and the company's ability to finance business development.